The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

A technological solution for the management of diabetes in people who require intensive
insulin therapy has been sought for decades. The last 10 years have seen substantial …

In adults with type 2 diabetes, the benefits of fully closed-loop insulin delivery, which does
not require meal bolusing, are unclear. In an open-label, single-center, randomized …

Diabetes mellitus refers to a group of metabolic disorders which affect how the body uses
glucose impacting approximately 9% of the population worldwide. This review covers the …

OBJECTIVE Automated insulin delivery (AID) has rarely been studied in adults with type 2
diabetes. We tested the feasibility of using AID for type 2 diabetes with the Omnipod 5 …

OBJECTIVE We evaluated the safety and efficacy of fully closed-loop with ultrarapid insulin
lispro in adults with type 1 diabetes and suboptimal glycemic control compared with insulin …

In developed countries, diabetes is the leading cause of chronic kidney disease (CKD) and
accounts for 50% of incidence of end stage kidney disease. Despite declining prevalence of …

The use of continuous subcutaneous insulin infusion (CSII) via insulin pumps is today
considered standard of care for type 1 diabetes (T1D). Closed‐loop systems combining …

Abstract Purpose of Review Closed-loop insulin pump systems (artificial pancreas)
represent the cutting edge of insulin delivery technology. There are only a few systems …

Insulin pumps and glucose sensors are effective in improving diabetes therapy and reducing
acute complications. The combination of both devices using an algorithm‐driven …